Concepedia

Shelly L. Lorey

SL

Statistics

Publications

24

Citations

1.5K

H-Index

20

Active since

2004

Affiliations

Vanderbilt University(Current)

Vanderbilt University Medical Center

Medizinische Hochschule Hannover

Middle Tennessee State University

Office of Infectious Diseases

Shelly L. Lorey is an author at Vanderbilt University specializing in life sciences, molecular oncology, and oncology.

ORCID

Publications per year

2004–2024

24

Publications

24

Interaction with WDR5 Promotes Target Gene Recognition and Tumorigenesis by MYC

Lance R. Thomas, Qingguo Wang, Brian C. Grieb et al. · Molecular Cell · 2015 · 317 citations · Full text

, , +11

Interaction of the oncoprotein transcription factor MYC with its chromatin cofactor WDR5 is essential for tumor maintenance

Lance R. Thomas, Clare M. Adams, Jing Wang et al. · Proceedings of the National Academy of Sciences · 2019 · 124 citations · Full text

, , +14

Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity

Erin R. Aho, Jing Wang, Rocco D. Gogliotti et al. · Cell Reports · 2019 · 123 citations · Full text

, , +10

MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor–1

Tessa M. Popay, Jing Wang, Clare M. Adams et al. · eLife · 2021 · 103 citations · Full text

, , +15

Inhibition of MYC by the SMARCB1 tumor suppressor

April M. Weissmiller, Jing Wang, Shelly L. Lorey et al. · Nature Communications · 2019 · 89 citations · Full text

, , +17

1–5 of 24